Herantis Pharma (Finland) Analysis
| HRTIS Stock | EUR 1.49 0.07 4.49% |
Herantis Pharma Oyj is overvalued with Real Value of 1.26 and Hype Value of 1.56. The main objective of Herantis Pharma stock analysis is to determine its intrinsic value, which is an estimate of what Herantis Pharma Oyj is worth, separate from its market price. There are two main types of Herantis Pharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Herantis Pharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Herantis Pharma's stock to identify patterns and trends that may indicate its future price movements.
The Herantis Pharma stock is traded in Finland on Helsinki Exchange, with the market opening at 10:00:00 and closing at 18:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Finland. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Herantis Pharma's ongoing operational relationships across important fundamental and technical indicators.
Herantis |
Herantis Stock Analysis Notes
About 32.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.25. Herantis Pharma Oyj had not issued any dividends in recent years. The entity had 1737:1652 split on the 4th of May 2022. Herantis Pharma Oyj, a drug development company, focuses on developing regenerative therapeutics. The company was founded in 2008 and is based in Espoo, Finland. Herantis Pharma operates under Pharmaceuticals And Biosciences classification in Finland and is traded on Helsinki Exchange. It employs 13 people. To learn more about Herantis Pharma Oyj call Antti D at 358 9222 1195 or check out https://www.herantis.com.Herantis Pharma Oyj Investment Alerts
| Herantis Pharma Oyj may become a speculative penny stock | |
| Herantis Pharma Oyj has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (12.77 M) with profit before overhead, payroll, taxes, and interest of 90 K. | |
| Herantis Pharma Oyj has accumulated about 7.86 M in cash with (9.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.81. | |
| Roughly 32.0% of the company shares are held by company insiders |
Herantis Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 39.58 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Herantis Pharma's market, we take the total number of its shares issued and multiply it by Herantis Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 27th of December, Herantis Pharma retains the Downside Deviation of 2.43, market risk adjusted performance of (0.42), and Risk Adjusted Performance of 0.035. Herantis Pharma technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Herantis Pharma Oyj Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Herantis Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Herantis Pharma Oyj. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Herantis Pharma Outstanding Bonds
Herantis Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Herantis Pharma Oyj uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Herantis bonds can be classified according to their maturity, which is the date when Herantis Pharma Oyj has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Herantis Pharma Predictive Daily Indicators
Herantis Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Herantis Pharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 4531.88 | |||
| Daily Balance Of Power | (0.47) | |||
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 1.53 | |||
| Day Typical Price | 1.51 | |||
| Price Action Indicator | (0.07) | |||
| Period Momentum Indicator | (0.07) |
Herantis Pharma Forecast Models
Herantis Pharma's time-series forecasting models are one of many Herantis Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Herantis Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Herantis Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Herantis Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Herantis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Herantis Pharma. By using and applying Herantis Stock analysis, traders can create a robust methodology for identifying Herantis entry and exit points for their positions.
Herantis Pharma Oyj, a drug development company, focuses on developing regenerative therapeutics. The company was founded in 2008 and is based in Espoo, Finland. Herantis Pharma operates under Pharmaceuticals And Biosciences classification in Finland and is traded on Helsinki Exchange. It employs 13 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Herantis Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Complementary Tools for Herantis Stock analysis
When running Herantis Pharma's price analysis, check to measure Herantis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Herantis Pharma is operating at the current time. Most of Herantis Pharma's value examination focuses on studying past and present price action to predict the probability of Herantis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Herantis Pharma's price. Additionally, you may evaluate how the addition of Herantis Pharma to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |